- Filed
- Jan 26, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · Dec 12, 2022 | 8.09B sh |
| Capex | Q1 2020 · Mar 31, 2020 | $2.67K |
| Capex | Q1 2020 · Mar 31, 2019 | $17.32K |
| Operating Cash Flow | Q1 2020 · Mar 31, 2020 | −$194.02K |
| Operating Cash Flow restated | Q1 2020 · Mar 31, 2019 | −$785.11K |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $11.87K |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $4.46K |
| Cash And Equivalents | Q1 2020 · Mar 31, 2019 | $34.91K |
| Cash And Equivalents | Q1 2020 · Dec 31, 2018 | $87.83K |
| Stockholders Equity | Q1 2020 · Mar 31, 2020 | −$11.84M |
| Stockholders Equity | Q1 2020 · Dec 31, 2019 | −$6.54M |
| Stockholders Equity | Q1 2020 · Mar 31, 2019 | −$2.73M |
| Stockholders Equity restated | Q1 2020 · Dec 31, 2018 | −$1.76M |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $13.23M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $8.04M |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $14.84M |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $9.72M |
| Current Assets | Q1 2020 · Mar 31, 2020 | $47.13K |
| Current Assets | Q1 2020 · Dec 31, 2019 | $151.4K |
| Total Assets | Q1 2020 · Mar 31, 2020 | $3M |
| Total Assets | Q1 2020 · Dec 31, 2019 | $3.18M |
| Net Income | Q1 2020 · Mar 31, 2020 | −$6.2M |
| Net Income | Q1 2020 · Mar 31, 2019 | −$2M |
| Operating Income | Q1 2020 · Mar 31, 2020 | −$441.57K |
| Operating Income | Q1 2020 · Mar 31, 2019 | −$872.57K |
| Gross Profit | Q1 2020 · Mar 31, 2020 | $31.73K |
| Gross Profit | Q1 2020 · Mar 31, 2019 | $104.17K |
| Cost Of Revenue | Q1 2020 · Mar 31, 2020 | $49.41K |
| Cost Of Revenue | Q1 2020 · Mar 31, 2019 | $82.36K |